{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:55:54Z","timestamp":1781585754675,"version":"3.54.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>We provide here an up-to-date perspective on the potential use of LDL particle number and size as complementary risk factors to predict and manage cardiovascular disease (CVD) risk in the clinical realm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Studies show that a significant proportion of the population has discordant LDL particle number and cholesterol indices [non-HDL cholesterol (HDL-C)]. Data also show that risk prediction may be improved when using information on LDL particle number in patients with discordant particle number and cholesterol data. Yet, most of the current CVD guidelines conclude that LDL particle number is not superior to cholesterol indices, including non-HDL-C concentrations, in predicting CVD risk. LDL particle size, on the other hand, has not been independently associated with CVD risk after adjustment for other risk factors such as LDL cholesterol, triglycerides, and HDL-C and that routine use of information pertaining to particle size to determine and manage patients\u2019 risk is not yet justified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Additional studies are required to settle the debate on which of cholesterol indices and LDL particle number is the best predictor of CVD risk, and if such measures should be integrated in clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000419","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T20:01:31Z","timestamp":1491508891000},"page":"261-266","source":"Crossref","is-referenced-by-count":27,"title":["LDL particle number and size and cardiovascular risk: anything new under the sun?"],"prefix":"10.1097","volume":"28","author":[{"given":"Janie","family":"Allaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Vors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Lamarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/clinchem\/38.9.1632","article-title":"Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement","volume":"38","author":"Otvos","year":"1992","journal-title":"Clin Chem"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacl.2014.11.005","article-title":"Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice","volume":"9","author":"Varvel","year":"2015","journal-title":"J Clin Lipidol"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1373\/clinchem.2012.196733","article-title":"Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC lipoprotein and vascular diseases division working group on best practices","volume":"59","author":"Cole","year":"2013","journal-title":"Clin Chem"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.amjcard.2016.10.028","article-title":"Cost effectiveness of achieving targets of low-density lipoprotein particle number versus low-density lipoprotein cholesterol level","volume":"119","author":"Grabner","year":"2017","journal-title":"Am J Cardiol"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-2275(20)38178-5","article-title":"Identification of multiple subclasses of plasma low density lipoproteins in normal humans","volume":"23","author":"Krauss","year":"1982","journal-title":"J Lipid Res"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/clinchem\/47.2.266","article-title":"Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL system","volume":"47","author":"Hoefner","year":"2001","journal-title":"Clin Chem"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11745-011-3611-8","article-title":"Lipoprint adequately estimates LDL size distribution, but not absolute size, versus polyacrylamide gradient gel electrophoresis","volume":"46","author":"Varady","year":"2011","journal-title":"Lipids"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/157489009787260034","article-title":"Rapid and simple profiling of lipoproteins by polyacrylamide-gel disc electrophoresis to determine the heterogeneity of low-density lipoproteins (LDLs) including small, dense LDL","volume":"4","author":"Nakano","year":"2009","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1373\/clinchem.2007.100586","article-title":"Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis","volume":"54","author":"Caulfield","year":"2008","journal-title":"Clin Chem"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jacl.2016.01.007","article-title":"Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes","volume":"10","author":"Shah","year":"2016","journal-title":"J Clin Lipidol"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1194\/jlr.D050120","article-title":"Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy","volume":"56","author":"Mallol","year":"2015","journal-title":"J Lipid Res"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/2047487316653709","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR)","volume":"23","author":"Piepoli","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"(Suppl 2)","key":"R14-20230917","first-page":"ii1","article-title":"Joint British Societies\u2019 consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","author":"Boon","year":"2014","journal-title":"Heart"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1: executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R16-20230917","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2013","journal-title":"Circulation"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5551\/jat.15792","article-title":"Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan: 2012 version","volume":"20","author":"Teramoto","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","article-title":"An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia: full report","volume":"8","author":"Grundy","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cjca.2016.07.510","article-title":"2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MOL.0000000000000127","article-title":"Discordance analysis and the gordian knot of LDL and non-HDL cholesterol versus apoB","volume":"25","author":"Sniderman","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/CIRCULATIONAHA.115.016857","article-title":"Atherogenic lipoprotein subfractions determined by ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) trial","volume":"132","author":"Mora","year":"2015","journal-title":"Circulation"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"e000759","DOI":"10.1161\/JAHA.113.000759","article-title":"Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials","volume":"3","author":"Thanassoulis","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/2047487315569411","article-title":"Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C","volume":"22","author":"Pencina","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jacl.2007.10.001","article-title":"LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - implications for LDL management","volume":"1","author":"Cromwell","year":"2007","journal-title":"J Clin Lipidol"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low-density lipoprotein subclass patterns and risk of myocardial infarction","volume":"260","author":"Austin","year":"1988","journal-title":"JAMA"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MOL.0000000000000067","article-title":"The composition and metabolism of large and small LDL","volume":"25","author":"Diffenderfer","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MOL.0b013e32833b7756","article-title":"Lipoprotein subfractions and cardiovascular disease risk","volume":"21","author":"Krauss","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/hc4401.098490","article-title":"Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease","volume":"104","author":"St-Pierre","year":"2001","journal-title":"Circulation"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201706000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T07:04:15Z","timestamp":1694934255000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201706000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000419","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}